Janux Therapeutics, Inc. (JANX)
13.26
+0.18
(+1.42%)
USD |
NASDAQ |
Feb 09, 16:00
13.26
0.00 (0.00%)
After-Hours: 20:00
Janux Therapeutics EPS Diluted (Quarterly) : -0.392 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 0.5326 |
| Eli Lilly & Co. | 7.390 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| MannKind Corp. | 0.0256 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.31M |
| Revenue (Quarterly) | 10.00M |
| Total Expenses (Quarterly) | 34.31M |
| Enterprise Value | -180.20M |
| Gross Profit Margin (Quarterly) | 94.99% |
| Profit Margin (Quarterly) | -243.1% |
| Earnings Yield | -12.64% |
| Normalized Earnings Yield | -12.64 |